The novel therapy of this peptide represents a significant development in the handling of the condition. Unlike existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide031617.blogofoto.com/73506286/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment